Search research articles
Contact Us
Filters
Showing results (91-100 of 157) with videos related to
Page
of 16
Sort By:
Archives of Pathology & Laboratory Medicine
|
July 1, 2026
Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites
Swati Bhardwaj, Eli Morris, Aditya Halthore, et al.
Clinical Genitourinary Cancer
|
December 28, 2020
Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience
Jean Hoffman-Censits, Woonyoung Choi, Trinity J Bivalacqua, et al.
The Journal of Pathology. Clinical Research
|
February 19, 2025
Sarcomatoid areas of urothelial carcinoma are enriched for CD163-positive antigen-presenting cells
Burles A Johnson, Vamsi Parimi, Sonia Kamanda, et al.
The Journal of Urology
|
May 16, 2022
Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Nonmuscle-Invasive Bladder Cancer
Max Kates, Ahmed M Mansour, Donald L Lamm, et al.
World Journal of Urology
|
April 29, 2019
Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor
Oudai Hassan, Belkiss Murati Amador, Kara A Lombardo, et al.
The Journal of Urology
|
March 25, 2026
UGN-102 for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer: 24-Month Duration of Response Results From the Phase 3 ENVISION Trial
Sandip M Prasad, Dimitar Shishkov, Nikola Vladimirov Mihaylov, et al.
Urology Practice
|
November 11, 2025
Patient-Reported Outcomes Following UGN-102 Treatment in Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: An Analysis of 3 Clinical Trials
Charles C Peyton, Max Kates, Anagha Nadkarni, et al.
Urologic Oncology
|
October 25, 2016
Longer average blood storage duration is associated with increased risk of infection and overall morbidity following radical cystectomy
Meera R Chappidi, Heather J Chalfin, Daniel J Johnson, et al.
The Journal of Urology
|
April 29, 2026
Reply by Authors
Sandip M Prasad, Dimitar Shishkov, Nikola V Mihaylov, et al.
Urology
|
February 13, 2018
Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method
Heather J Chalfin, Max Kates, Emma E van der Toom, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 157) with videos related to
Sort By:
Page
of 16
Archives of Pathology & Laboratory Medicine
|
July 1, 2026
Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites
Swati Bhardwaj, Eli Morris, Aditya Halthore, et al.
Clinical Genitourinary Cancer
|
December 28, 2020
Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience
Jean Hoffman-Censits, Woonyoung Choi, Trinity J Bivalacqua, et al.
The Journal of Pathology. Clinical Research
|
February 19, 2025
Sarcomatoid areas of urothelial carcinoma are enriched for CD163-positive antigen-presenting cells
Burles A Johnson, Vamsi Parimi, Sonia Kamanda, et al.
The Journal of Urology
|
May 16, 2022
Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Nonmuscle-Invasive Bladder Cancer
Max Kates, Ahmed M Mansour, Donald L Lamm, et al.
World Journal of Urology
|
April 29, 2019
Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor
Oudai Hassan, Belkiss Murati Amador, Kara A Lombardo, et al.
The Journal of Urology
|
March 25, 2026
UGN-102 for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer: 24-Month Duration of Response Results From the Phase 3 ENVISION Trial
Sandip M Prasad, Dimitar Shishkov, Nikola Vladimirov Mihaylov, et al.
Urology Practice
|
November 11, 2025
Patient-Reported Outcomes Following UGN-102 Treatment in Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: An Analysis of 3 Clinical Trials
Charles C Peyton, Max Kates, Anagha Nadkarni, et al.
Urologic Oncology
|
October 25, 2016
Longer average blood storage duration is associated with increased risk of infection and overall morbidity following radical cystectomy
Meera R Chappidi, Heather J Chalfin, Daniel J Johnson, et al.
The Journal of Urology
|
April 29, 2026
Reply by Authors
Sandip M Prasad, Dimitar Shishkov, Nikola V Mihaylov, et al.
Urology
|
February 13, 2018
Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method
Heather J Chalfin, Max Kates, Emma E van der Toom, et al.
Page
of 16